Company / Profit Margin
Coherus Oncology, Inc. Profit Margin History
FY2014-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-15306.6%
FY2017
5-year range
-15306.6% / -280.1%
FY2014-FY2017
Trend
-5364.3%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin changed -5364% YoY in FY2017, a notable deviation from the 3-year average annual change of -1764%.
Based on SEC 10-K filings.
-15306.6% in FY2017 with a 3-year CAGR of -13567.9%.
Declined from -1949.7% to -15306.6% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -13567.9pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2017, profit margin decreased 5364.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | -15306.6% | -5364.3% |
| FY2016 | -280.1% | +85.6% |
| FY2015 | -1949.7% | -12.1% |
| FY2014 | -1738.7% | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026